Activity not yet confirmed Verified 5 Nov 2026
Optum Ventures
Boston corporate venture arm of Optum investing in healthcare companies from seed to growth, with an office in London.
- Type
- Corporate VC
- Location
- Boston, Massachusetts, United States
- Stages
- Seed, Series A, Series B, Growth
- Backs
- Medtech and digital health, B2B software
- Sectors
- Healthtech and life sciences, AI
- Fund size / AUM
- $3B gross private fund assets (Form ADV; private funds: 7, of which venture capital: 7)
- Portfolio mix
- Medtech and digital health 56%; B2B software 33%; Fintech 7%; Tech-enabled services 4% (n=30, 2022 to 2026)
- UK office
- London
- Website
- optumventures.com
Contacts on file
For Optum Ventures, the paid file holds: 8 named decision-makers with roles; firm contact email (domain checked).
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
AdaptiveAlmaAmbience HealthcareCareBridge
Sources
- adviserinfo.sec.gov/firm/summary/290116
- www.optumventures.com/
- www.optumventures.com/portfolio
- www.optumventures.com/our-team
- www.optumventures.com/about
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 60 lists
Corporate venture capital firms in the US (17)Series A investors in Massachusetts (18)Growth-stage investors in Massachusetts (18)Series B medtech investors in the US (36)Medtech investors in Massachusetts (37)SaaS investors in Massachusetts (55)Series B medtech investors (57)Healthtech investors in Massachusetts (58)Seed investors in Massachusetts (60)AI investors in Massachusetts (61)International investors with a UK office (67)Series B healthtech investors in the US (69)Growth-stage medtech investors in the US (69)Series A medtech investors in the US (76)Corporate venture capital firms (84)Growth-stage medtech investors (107)Series B SaaS investors in the US (108)Growth-stage healthtech investors in the US (121)Series A medtech investors (125)Series B AI investors in the US (126)Series B healthtech investors (160)Growth-stage AI investors in the US (162)Growth-stage SaaS investors in the US (162)Series A healthtech investors in the US (164)Series B investors in the US (165)Venture capital firms in Massachusetts (185)Series B SaaS investors (196)Series B AI investors (204)Seed medtech investors in the US (205)Series A SaaS investors in the US (256)Seed medtech investors (278)Series A AI investors in the US (280)Growth-stage investors in the US (288)Growth-stage AI investors (295)Growth-stage healthtech investors (316)Series B investors (339)Growth-stage SaaS investors (344)Medtech venture capital firms in the US (350)Series A investors in the US (372)Series A healthtech investors (401)Seed healthtech investors in the US (437)Medtech investors (457)Series A SaaS investors (475)Series A AI investors (500)Seed SaaS investors in the US (666)Growth-stage investors (705)Healthtech venture capital firms in the US (709)Seed AI investors in the US (724)Seed healthtech investors (800)Series A investors (864)Seed SaaS investors (1,010)Seed investors in the US (1,043)SaaS venture capital firms in the US (1,049)Seed AI investors (1,082)AI venture capital firms in the US (1,112)Healthtech investors (1,207)SaaS investors (1,529)AI investors (1,576)Seed investors (1,892)Venture capital firms in the US (2,975)